Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Twenty years after the discovery of HIV, there is still no vaccine. This year, an envelope vaccine aimed at stimulating neutralizing antibodies was unable to protect against infection in phase 3 trials. But more than 20 HIV vaccines designed to stimulate T-cell responses are being developed. Will any of them work?

Original publication

DOI

10.1038/nm0703-874

Type

Journal article

Journal

Nat Med

Publication Date

07/2003

Volume

9

Pages

874 - 880

Keywords

AIDS Vaccines, Antibodies, CD8-Positive T-Lymphocytes, Clinical Trials as Topic, Drug Design, HIV, Humans, T-Lymphocytes, Vaccines, Synthetic